Home » Health » New JN.1 Coronavirus Variant on the Rise in the United States as Winter Peaks

New JN.1 Coronavirus Variant on the Rise in the United States as Winter Peaks

A rise in infections has been recorded for a new mutant of the Coronavirus in the United States as winter approaches its peak. It is called “JN.1”, which is a sub-strain of the “Omicron” mutant.

In September, the first case of the JN.1 variant was detected, and its spread has been slow. But in recent weeks, a 20 percent increase in infections has been recorded. It is expected to be responsible for at least half of the new infections in the United States before the end of this month.

The World Health Organization classified the new JN.1 variant as “of interest” as a result of its rapid spread. However, it did not classify it as a cause for concern, and called on citizens to take preventive measures and wear masks, according to what was published on the website. Time.

What do we know about the new mutant?

This variant is closely related to BA.2.86, a variant of the Omicron strain that first appeared in the United States last summer. According to the Centers for Disease Control and Prevention (CDC). The two variants are largely identical except for one difference in the spike protein, the part of the virus that allows it to enter human cells.

The new mutant is considered responsible for the infections recorded today, and the CDC indicates that it is responsible for the increase in infection because it is more widespread or better at bypassing our bodies’ immune defenses than previous variants of the virus.

However, there is no evidence that it causes more severe disease than other viral strains, although it is responsible for an increase in transmission.

As for the symptoms, they are similar to the symptoms of the previous variants, the most important of which are:

* fever

* Sore or itchy throat

* Tired

* Headache

*Congestion

* Cough

Accordingly, to date, the indicators appear positive about this variant, and it is expected that Covid-19 tests and treatments will be effective against the JN.1 variant. Although the latest booster dose against the virus was designed to target the XBB.1.5 variant, preliminary research indicates that it also generates antibodies that work against the new variant.

Vaccines will also not prevent transmission, but they reduce the possibility of death and severe illness.

2023-12-20 17:35:33

#interesting #coronavirus #variant #return #mask

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.